The role of circadian rhythm on the pharmacokinetic of methotrexate in streptozotocin-induced diabetes mellitus rats

References

• Akhani , SP , Vishwakarma , SL and Goyal , RK . 2004 . Anti-diabetic activity of Zingiber officinale in streptozotocin-induced type I diabetic rats . J Pharm Pharmacol , 56 ( 1 ) : 101 – 105 .
   PubMed Web of Science ®Google Scholar
• Balis , FM , Jeffries , SL , Lange , B , Murphy , RF , Doherty , KM , Arndt , CA , Luery , N and Poplack , DG . 1989 . Chronopharmacokinetics of oral methotrexate and 6-mercaptopurine: is there diurnal variation in the disposition of antileukemic therapy? . Am J Pediatr Hematol Oncol , 11 ( 3 ) : 324 – 326 .
   PubMedGoogle Scholar
• Bjarnason , GA . 1995 . Clinical chronotolerance to anticancer drugs: relevance for dose-intensity . In vivo , 9 ( 6 ) : 557 – 564 .
   PubMedGoogle Scholar
• Courtois , A , Payen , L , Guillouzo , A and Fardel , O . 1999 . Up-regulation of multidrug resistance- associated protein 2 (MRP2) expression in rat hepatocytes by dexamethasone . FEBS Lett , 459 ( 3 ) : 381 – 385 .
   PubMed Web of Science ®Google Scholar
• English , J , Aherne , GW , Arendt , J and Marks , V . 1987 . The effect of abolition of the endogenous corticosteroid rhtyme on the circadian variation in methotrexate toxicity in the rat . Cancer Chemother Pharmacol , 19 ( 49 ) : 287 – 290 .
   PubMedGoogle Scholar
• Ferrazzini , G , Sohl , H and Robieux , I . 1991 . Diurnal variations of methotrexate disposition in children with acute leukemia . Eur J Clin Pharmacol , 41 ( 5 ) : 425 – 427 .
   PubMed Web of Science ®Google Scholar
• Gwilt , PR , Nahhas , RR and Tracewell , WG . 1991 . The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans . Clin Pharmacokinet , 20 ( 6 ) : 477 – 490 .
   PubMed Web of Science ®Google Scholar
• Ikegami-Kawai , M , Okuda , R , Nemoto , T , Inada , N and Takahashi , T . 2004 . Enhanced activity of serum and urinary hyaluronidases in streptozotocin-induced diabetic Wistar and GK rats . Glycobiology , 14 ( 1 ) : 65 – 72 .
   PubMed Web of Science ®Google Scholar
• Kim , SH , Kim , WB and Lee , MG . 1998 . Pharmacokinetics of a new carbapenem, DA-1131, after intravenous administration to rats with alloxan-induced diabetes mellitus . Biopharm Drug Dispos , 19 : 303 – 308 .
   PubMed Web of Science ®Google Scholar
• Koren , G , Langevin , AM , Olivieri , N , Giesbrecht , E , Zipursky , A and Greenberg , M . 1990 . Diurnal variation in the pharmacokinetics and myelotoxicity of mercaptopurine in children with acute lymphocytic leukemia . Am J Dis Child , 144 ( 10 ) : 1135 – 1137 .
   PubMedGoogle Scholar
• Koren , G , Ferrazzini , G , Sohl , H , Robieux , I , Johnson , D and Giesbrecht , E . 1992 . Chronopharmacology of methotrexate pharmacokinetics in childhood leukemia . Chronobiol Int , Dec 9 ( 6 ) : 434 – 438 .
   PubMed Web of Science ®Google Scholar
• Labat , C , Mansour , K , Malmary , MF , Terrissol , M and Oustrin , J . 1987 . Chronotoxicity of methotrexate in mice after intraperitoneal administration . Chronobiologia , 14 ( 3 ) : 267 – 275 .
   PubMedGoogle Scholar
• Levi , FA , Hrushesky , WJ , Halberg , F , Langevin , TR , Haus , E and Kennedy , BJ . 1982 . Lethal nephrotoxicity and hematologic toxicity of cis-diamminedichloroplatinum ameliorated by optimal circadian timing and hydration . Eur J Cancer Clin Oncol , 18 ( 5 ) : 471 – 477 .
   PubMedGoogle Scholar
• Lin , SH , Cheema-Dhadli , S , Chayaraks , S , Chen , CB , Gowrishankar , M and Halperin , ML . 1998 . Physiological disposal of the potential alkali load in diet of the rat: steps to achieve acid-base balance . Am J Physiol Renal Physiol , 274 ( 6 ) : 1037 – 1044 .
   Web of Science ®Google Scholar
• Moon , CH , Lee , HJ , Jung , YS , Lee , SH and Baik , EJ . 1998 . Pharmacokinetics of losartan and its metabolite, EXP3174, after intravenous and oral administration of losartan to rats with streptozotocin-induced diabetes mellitus . Res Commun Mol Pathol Pharmacol , 101 ( 2 ) : 147 – 158 .
   PubMedGoogle Scholar
• Nadai , M , Yoshizumi , H , Kuzuya , T , Hasegawa , T , Johno , I and Kitazawa , S . 1990 . Effect of diabetes on disposition and renal handling of cefazolin in rats . Drug Metab Dispos , 18 ( 5 ) : 565 – 570 .
   PubMed Web of Science ®Google Scholar
• O'Connor , P and Feely , J . 1987 . Clinical pharmacokinetics and endocrine disorders. Therapeutic implications . Clin Pharmacokinet , 13 ( 6 ) : 345 – 364 .
   PubMed Web of Science ®Google Scholar
• Park , JM , Moon , CH and Lee , MG . 1996 . Pharmacokinetic changes of methotrexate after intravenous administration to streptozotocin-induced diabetes mellitus rats . Res Commun Mol Pathol Pharmacol , 93 ( 3 ) : 343 – 352 .
   PubMedGoogle Scholar
• Premaud , A , Rousseau , A , Gicquel , M , Ragot , S , Manceau , J , Laurentie , M and Marquet , P . 2002 . An animal model for the study of chronopharmacokinetics of drugs and application to Methotrexate and Vinorelbine . Toxicol and Applied Pharm , 183 : 189 – 197 .
   PubMed Web of Science ®Google Scholar
• Radziuk , J and Pye , S . 2002 . Quantitation of basal endogenous glucose production in Type II diabetes . Diabetologia , 45 : 1053 – 1084 .
   PubMed Web of Science ®Google Scholar
• Radziuk , J and Pye , S . 2004 . Endogenous Glucose Production in Type 2 Diabetes: Basal and Postprandial, Role of Diurnal Rhythms . J Investig Med , 52 ( 6 ) : 379 – 388 .
   PubMed Web of Science ®Google Scholar
• Ramanan , AV , Whitworth , P and Baildam , EM . 2003 . Use of methotrexate in juvenile idiopathic arthritis . Arch Dis Child , 88 : 197 – 200 .
   PubMed Web of Science ®Google Scholar
• Schmidt , RE , Dorsey , DA , Beaudet , LN , Parvin , CA , Zhang , W and Sima , AA . 2004 . Experimental rat models of types 1 and 2 diabetes differ in sympathetic neuroaxonal dystrophy . J Neuropathol Exp Neurol , 63 ( 5 ) : 450 – 460 .
   PubMed Web of Science ®Google Scholar
• Velasco , A , Huerta , I , Granda , T , Cachero , TG , Menendez , E and Marin , B . 1993 . Circadian rhythms of plasma corticosterone at different times after induction of diabetes. Responses to corticoadrenal stimulation in light and dark phases . Life Sci , 52 ( 11 ) : 965 – 974 .
   PubMed Web of Science ®Google Scholar